as on September 17, 2025 at 4:01 pm IST
Market Cap
₹25,780.72 Cr
Return on Equity (ROE)
12.79
PE Ratio (TTM)
34.67
Return on capital employed (ROCE)
14.36
Industry PE ratio
42.14
Beta (LTM)
1.17
P/B Ratio
6.72
Dividend Yield
0.28
PEG Ratio
3.16
Quarterly Earnings Growth YOY
40.76
EPS (TTM)
37.34
Sector
Pharmaceuticals
Book Value
234.65
Technical Analysis
Bearish
View Technical Analysis
as on September 17, 2025 at 4:01 pm IST
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (34.67x)
September 16, 2025
Industry (42.14x)
September 16, 2025
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 34.67x
Compare market cap, revenue, PE, and other key metrics of Emcure Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 25,780.72 | 0.02% | 0.63 | 707 | 7,896 | |
BUY | 8,080.46 | 8.35% | 0.60 | 78 | 1,286 | |
NA | 10.41 | -10.65% | 0.50 | -2 | 35 | |
NA | 1,699.52 | 192.71% | 0.51 | 49 | 465 | |
NA | 1,754.97 | 4.93% | 0.74 | 28 | 311 |
Based on 4 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Emcure Pharmaceuticals Ltd. Average target price of ₹1652.5
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Emcure Pharmaceuticals Ltd.
What analysts predicted
21.47%UPSIDE
Target Price
₹1652.5
Current Price
₹1355
Analyzed by
4 Analysts
High
₹1740
Target
₹1652.50
Low
₹1550
Emcure Pharmaceuticals Ltd target price ₹1652.5, a slight upside of 21.47% compared to current price of ₹1355. According to 4 analysts rating.
Source: S&P Global Market Intelligence
Search interest for Emcure Pharmaceuticals Ltd Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd’s net profit jumped 43.64% since last year same period to ₹206.95Cr in the Q1 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 9.52% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.00 per share on 22 May 2025 - translating a dividend yield of 0.22%.
Read More about DividendsCheck stock indices that include Emcure Pharmaceuticals Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 15.57% to 16.39% in Jun 2025 quarter
MF Holding Down
Mutual Funds have decreased holdings from 2.73% to 2.34% in Jun 2025 quarter
Price Dip
In the last 1 month, EMCURE stock has moved down by -6.4%
Promoter Holding Down
Promoters have decreased holdings from 77.92% to 77.91% in Jun 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 3.07% to 2.86% in Jun 2025 quarter
Organisation | Emcure Pharmaceuticals Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Emcure Pharmaceuticals Ltd share price today stands at ₹1355 as on at the close of the market. Emcure Pharmaceuticals Ltd share today touched a day high of ₹1369.9 and a low of ₹1348.1.
Emcure Pharmaceuticals Ltd touched a 52 week high of ₹1580 and a 52 week low of ₹889. Emcure Pharmaceuticals Ltd share price today i.e. is closed at ₹1355, which is -14.24% down from its 52 week high and 52.42% up from its 52 week low.
Emcure Pharmaceuticals Ltd market capitalisation is ₹25,780.72 Cr as on .
To buy Emcure Pharmaceuticals Ltd shares, you need to follow these steps:
Emcure Pharmaceuticals Ltd trading volume is 1.60L as on . This means that 1.60L shares of Emcure Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.